Atlas Trials

Compare Immunological Efficacy of a Vaccine Regimen Combining Two Covid19 mRNA Vaccines (Pfizer-BioNTech and Moderna) With That of a Homologous Vaccination of Each Covid19 mRNA Vaccine

Clinical trial NCT04900467 · UNKNOWN

Trial details

NCT number
NCT04900467
Sponsor
Assistance Publique - Hôpitaux de Paris
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Adult Who Received a First Dose of an mRNA Vaccine (Pfizer-BioNTech or Moderna) and Need to Receive a Second Dose
Start date
2021-05-28
Primary completion
2021-07-02
Enrollment
418

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.